Outcomes of patients with advanced solid tumors who discontinued immune-checkpoint inhibitors: a systematic review and meta-analysisResearch in context

Summary: Background: The outcome of patients with metastatic tumors who discontinued immune checkpoint inhibitors (ICIs) not for progressive disease (PD) has been poorly explored. We performed a meta-analysis of all studies reporting the clinical outcome of patients who discontinued ICIs for reason...

Descrición completa

Detalles Bibliográficos

Principais autores:	Laura Pala, Eleonora Pagan, Isabella Sala, Chiara Oriecuia, Matteo Oliari, Tommaso De Pas, Claudia Specchia, Emilia Cocorocchio, Emma Zattarin, Giovanna Rossi, Chiara Catania, Giovanni Luca Ceresoli, Daniele Laszlo, Jacopo Canzian, Elena Valenzi, Giuseppe Viale, Richard D. Gelber, Alberto Mantovani, Vincenzo Bagnardi, Fabio Conforti
Formato:	Artigo
Idioma:	Inglês
Publicado:	Elsevier 2024-07-01
Series:	EClinicalMedicine
Assuntos:	Immune-checkpoint inhibitors Discontinuation Meta-analysis melanoma NSCLC
Acceso en liña:	http://www.sciencedirect.com/science/article/pii/S2589537024002608
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!